Acute lymphoid leukemia developing in the course of Crohn's Disease: Are there any guilty agents?

• Hoofdauteurs: Nergiz Ekmen (Auteur), Güray Can (Auteur), Hadi Sasani (Auteur)
• Formaat: Boek
• Gepubliceerd in: National Scientific Medical Center, 2021-06-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Anti-tumor necrosis factor-alpha drugs (anti-TNF-α), which are monoclonal antibodies, have revolutionized the treatment of severe and refractory inflammatory bowel disease in the last two decades. However, these drugs pose a risk for the formation of hematological malignancies such as lymphoma and a...